Meningitis Outbreak Exposes FDA's Oversight Failures
As a fatal meningitis outbreak sparks calls for increased federal regulation of compounding pharmacies, industry experts say the real problem is not that the U.S. Food and Drug Administration lacks enforcement...To view the full article, register now.
Already a subscriber? Click here to view full article